Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers

Sign In \| Register \| About Pleasanton \| Contact Us
Pleasanton, CA September 01, 2020 1:32pm 7-Day Forecast \| Traffic

- American
- Asian
- Bakery
- Barbecue
- Breakfast
- Brew Pubs
- Burgers
- Cajun
- Chinese
- Coffee Houses
- Deli
- Fast Food
- Greek
- Hawaiian
- Ice Cream / Frozen Yogurt
- Indian
- Italian
- Japanese
- Korean
- Mexican
- Pizza
- Sandwiches
- Seafood
- Sports Bars
- Steaks, Chops
- Sushi
- Thai
- Vietnamese
- Apartments
- Classifieds
- Cars
- Forums
- Coupons
- News Archives
- Contests
- Free Email
- Jobs

Recent Quotes

My Watchlist

Indicators

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Photography by Christophe Tomatis

Search Hotels in Pleasanton

Find A Business

or Browse Listings

Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers